In a study funded by the charity Leukemia & Lymphoma Research published in the leukemia journal Blood in January, scientists from Newcastle University have discovered a gene variation that occurs in 20% of the population, which can have a substantial effect on treatment responses in patients with a rare type of blood cancer. The CD95 gene is one of the genes involved in controlling the death of ...